Scholars Central

Review articlePublished 15 Jul 2016

Disease-modifying drugs in multiple sclerosis: new oral options

Authors: Milena De Riz, Daniela Galimberti, Elio Scarpini

Clinical Practice

Volume 9 · Issue 3 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Multiple sclerosis is characterized by multifocal CNS lesions with perivenular inflammation, demyelination, axonal transection, neuronal degeneration and gliosis. Proinflammatory CD4+ and CD8+ T cells reactive to CNS myelin antigens mediate the initial phases of lesion formation. Other T‑cell subsets, B cells, monocyte-macrophages and natural killer cells have been implicated in both effector and regulatory mechanisms. Inflammatory processes predominate in early disease, whereas progression of neurological disability reflects neurodegeneration. A number of disease-modifying drugs with immunomodulatory (e.g., IFN‑b, glatiramer acetate and natalizumab) or immunosuppressant properties (e.g., mithoxantron) have been employed over the past two decades, in order to reduce the relapse rate. Unfortunately, they are limited by parenteral use. Recently, some new oral compounds have been developed reaching similar or higher control of disease activity, improving quality of life and increasing adherence. In this article, an update of main emerging oral disease-modifying drugs will be provided, including clinical trials design, mechanisms of action and safety aspects.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Milena De Riz”
  • BylineArticles whose byline prints “Daniela Galimberti”
  • BylineArticles whose byline prints “Elio Scarpini”